The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
The role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
"Celbenin" - resistant Staphylococci
Jevons, M. P. (1961) · BMJ · doi:10.1136/bmj.1.5219.124-a · Cited by 1,680
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., & Spratt, B. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122108599 · Cited by 1,588
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Chambers, H. F. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.781 · Cited by 1,127
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Murray, C. J. L., Ortblad, K. F., Guinovart, C., Lim, S. S., Wolock, T. M., Roberts, D. A., Dansereau, E. A., Graetz, N., Barber, R. M., Brown, J. C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60844-8 · Cited by 975
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 821
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Nonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807
Methicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
The changing epidemiology of resistance
Hawkey, P. M., & Jones, A. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp256 · Cited by 773
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 767
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 759
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Daniel, T. M. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.08.006 · Cited by 677
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
Fox, W., Ellard, G. A., & MITCHISON, D. A. (1999) · PubMed · Cited by 676
Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., & Pitt, T. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01021-06 · Cited by 657
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Mechanisms of Methicillin Resistance in Staphylococcus aureus
Peacock, S. J., & Paterson, G. K. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034516 · Cited by 656
The Future of Antibiotics and Resistance
Spellberg, B., Bartlett, J. G., & Gilbert, D. N. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1215093 · Cited by 647
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
Velayati, A. A., Masjedi, M. R., Farnia, P., Tabarsi, P., Ghanavi, J., ZiaZarifi, A. H., & Hoffner, S. E. (2009) · Chest · doi:10.1378/chest.08-2427 · Cited by 607
de Kraker, M. E. A., Davey, P. G., Grundmann, H., & on behalf of the BURDEN study group (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001104 · Cited by 599
Ma, X. X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., Daum, R. S., & Hiramatsu, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1147-1152.2002 · Cited by 587
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
Cellbenin-resistant staphylococci.
Jevons, M. P. (1961) · Medical Entomology and Zoology · Cited by 555
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 512
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Livermore, D. M., & Woodford, N. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.07.008 · Cited by 510
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
Dortet, L., Poirel, L., & Nordmann, P. (2014) · BioMed Research International · doi:10.1155/2014/249856 · Cited by 501
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527392 · Cited by 483
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lim, L. M., Ly, N., Anderson, D., Yang, J. C., Macander, L., Jarkowski, A., Forrest, A., Bulitta, J. B., & Tsuji, B. T. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.12.1279 · Cited by 444
Holden, M. T. G., Hsu, L.-Y., Kurt, K., Weinert, L. A., Mather, A. E., Harris, S. R., Strommenger, B., Layer, F., Witte, W., de Lencastre, H., et al. (2013) · Genome Research · doi:10.1101/gr.147710.112 · Cited by 440
Health Care–Associated Invasive MRSA Infections, 2005-2008
Kallen, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1115 · Cited by 439
Bush, K., & Fisher, J. F. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102911 · Cited by 419
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
Livermore, D. M. (2012) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2012.27.2.128 · Cited by 417
Resistance of Staphylococcus aureus to the Action of Penicillin.
Rammelkamp, C. H., & Maxon, T. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-51-13986 · Cited by 416
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins
Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff-Neutzling, R. M., & Wiedemann, B. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.302 · Cited by 415
Glycopeptide resistance in enterococci
ARTHUR, M., REYNOLDS, P., & COURVALIN, P. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10063-9 · Cited by 414
New antibiotics for bad bugs: where are we?
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-22 · Cited by 403
Rifampin: Mechanisms of Action and Resistance
Wehrli, W. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s407 · Cited by 397
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas, M. E., & Bliziotis, I. A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.12.012 · Cited by 393
Jaurin, B., & Grundström, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4897 · Cited by 390
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.024 · Cited by 378
Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-06 · Cited by 374
Go, E. S., Urban, C., Burns, J., Mariano, N., Mosinka-Snipas, K., Rahal, J. J., Kreiswirth, B., & Eisner, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90694-7 · Cited by 369
INFECTION BY PENICILLIN-RESISTANT STAPHYLOCOCCI
Barber, M., & Rozwadowska-Dowzenko, M. (1948) · The Lancet · doi:10.1016/s0140-6736(48)92166-7 · Cited by 368
Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections
Kluytmans, J. A. J. W., & Wertheim, H. F. L. (2005) · Infection · doi:10.1007/s15010-005-4012-9 · Cited by 360
Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A., Perroux, R., & Cluzel, R. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.3.323 · Cited by 358
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Carlet, J., Jarlier, V., Harbarth, S., Voss, A., Goossens, H., Pittet, D., & Forum, T. P. O. T. 3. W. H.-A. I. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-11 · Cited by 350
Otto, M. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01832.x · Cited by 342
Cohn, D. L., Bustreo, F., & Raviglione, M. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s121 · Cited by 340
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Stryjewski, M. E., & Corey, G. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit613 · Cited by 334
Acinetobacter infection – an emerging threat to human health
Visca, P., Seifert, H., & Towner, K. J. (2011) · IUBMB Life · doi:10.1002/iub.534 · Cited by 324
Society's failure to protect a precious resource: antibiotics
Carlet, J., Collignon, P., Goldmann, D., Goossens, H., Gyssens, I. C., Harbarth, S., Jarlier, V., Levy, S. B., N'Doye, B., Pittet, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60401-7 · Cited by 322
Tuberculosis, Drug Resistance, and the History of Modern Medicine
Keshavjee, S., & Farmer, P. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1205429 · Cited by 315
WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Maple, P. A. C., Hamilton-Miller, J. M. T., & Brumfitt, W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90076-7 · Cited by 312
Bayer, A. S., Schneider, T., & Sahl, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06819.x · Cited by 311
Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302
Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Gould, I. M., David, M. Z., Esposito, S., Garau, J., Lina, G., Mazzei, T., & Peters, G. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.028 · Cited by 294
Rozwarski, D. A., Vilchèze, C., Sugantino, M., Bittman, R., & Sacchettini, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15582 · Cited by 290
Pugh, R., Grant, C., Cooke, R. P., & Dempsey, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007577.pub3 · Cited by 289
Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance
Salverda, M. L. M., De Visser, J. A. G. M., & Barlow, M. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00222.x · Cited by 289
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Rodriguez-Bano, J., Navarro, M. D., Romero, L., Muniain, M. A., Cueto, M. D., Rios, M. J., Hernandez, J. R., & Pascual, A. (2006) · Clinical Infectious Diseases · doi:10.1086/508877 · Cited by 279
CTX-M: changing the face of ESBLs in the UK
Livermore, D. M., & Hawkey, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki239 · Cited by 278
Clermont, O., Lavollay, M., Vimont, S., Deschamps, C., Forestier, C., Branger, C., Denamur, E., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn084 · Cited by 274
Drug-resistant tuberculosis: time for visionary political leadership
Abubakar, I., Zignol, M., Falzon, D., Raviglione, M., Ditiu, L., Masham, S., Adetifa, I., Ford, N., Cox, H., Lawn, S. D., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70030-6 · Cited by 269
Poirel, L., Kämpfer, P., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4038-4040.2002 · Cited by 266
Streptomycin Resistance in Pulmonary Tuberculosis
Crofton, J., & Mitchison, D. A. (1948) · BMJ · doi:10.1136/bmj.2.4588.1009 · Cited by 261
Carbapenemase-Producing Enterobacteriaceae
Paterson, D., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257
Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis
Winder, F. G., & Collins, P. B. (1970) · Journal of General Microbiology · doi:10.1099/00221287-63-1-41 · Cited by 252
Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T., & Bodmer, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2054 · Cited by 250
Global tuberculosis control: lessons learnt and future prospects
Lienhardt, C., Glaziou, P., Uplekar, M., Lönnroth, K., Getahun, H., & Raviglione, M. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2797 · Cited by 250
Johnson, A. P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.143 · Cited by 247
Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Moellering, R. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr437 · Cited by 236
Canteón, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02679.x · Cited by 235
Schrag, S. J., Peña, C., Fernández, J., Sánchez, J., Gómez, V., Pérez, E., Feris, J. M., & Besser, R. E. (2001) · JAMA · doi:10.1001/jama.286.1.49 · Cited by 233
Fernandez-Cuenca, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg097 · Cited by 229
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
Falagas, M. E., Bliziotis, I. A., Kasiakou, S. K., Samonis, G., Athanassopoulou, P., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-24 · Cited by 224
First tuberculosis cases in Italy resistant to all tested drugs
Migliori, G. B., De Iaco, G., Besozzi, G., Centis, R., & Cirillo, D. M. (2007) · Weekly releases (1997–2007) · doi:10.2807/esw.12.20.03194-en · Cited by 219
Meehl, M., Herbert, S., Götz, F., & Cheung, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00209-07 · Cited by 216
The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus Aureus
Walsh, T. R., & Howe, R. A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160806 · Cited by 215
Nordmann, P., Naas, T., Fortineau, N., & Poirel, L. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.07.004 · Cited by 206
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
Sulis, G., Roggi, A., Matteelli, A., & Raviglione, M. C. (2014) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2014.070 · Cited by 205
Nimmo, G. R. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03822.x · Cited by 201
Saha, B., Singh, A. K., Ghosh, A., & Bal, M. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47144-0 · Cited by 195
Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus
Uhlemann, A.-C., Otto, M., Lowy, F. D., & DeLeo, F. R. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.04.030 · Cited by 194
SKINNER, D. (1941) · Archives of Internal Medicine · doi:10.1001/archinte.1941.00200110003001 · Cited by 192
Perry, J. D., Naqvi, S. H., Mirza, I. A., Alizai, S. A., Hussain, A., Ghirardi, S., Orenga, S., Wilkinson, K., Woodford, N., Zhang, J., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr299 · Cited by 188
The chemotherapy of tuberculosis: past, present and future [State of the art]
Mitchison, D., & Davies, G. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0083 · Cited by 185
Henry, R., Vithanage, N., Harrison, P., Seemann, T., Coutts, S., Moffatt, J. H., Nation, R. L., Li, J., Harper, M., Adler, B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05191-11 · Cited by 181
Sieradzki, K., & Tomasz, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.24.7103-7110.2003 · Cited by 181
The culturome of the human nose habitats reveals individual bacterial fingerprint patterns
Kaspar, U., Kriegeskorte, A., Schubert, T., Peters, G., Rudack, C., Pieper, D. H., Wos‐Oxley, M., & Becker, K. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.12891 · Cited by 175
Self-citationTotally drug‐resistant tuberculosis and adjunct therapies
Parida, S. K., Axelsson‐Robertson, R., Rao, M. V., Singh, N., Master, I., Lutckii, A., Keshavjee, S., Andersson, J., Zumla, A., & Maeurer, M. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12264 · Cited by 169
Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus
Hartman, B., & Tomasz, A. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.5.726 · Cited by 168
Lascols, C., Hackel, M., Marshall, S. H., Hujer, A. M., Bouchillon, S., Badal, R., Hoban, D., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr240 · Cited by 167
Talbot et al. (2006 42:657-68)
(2006) · Clinical Infectious Diseases · doi:10.1086/503200 · Cited by 166
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Azimian, A., Havaei, S. A., Fazeli, H., Naderi, M., Ghazvini, K., Samiee, S. M., Soleimani, M., & Peerayeh, S. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01727-12 · Cited by 157
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Evans, B. A., Hamouda, A., & Amyes, S. G. B. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804070285 · Cited by 157
Kos, V. N., Desjardins, C. A., Griggs, A. D., Cerqueira, G., van Tonder, A. J., Holden, M. T. G., Godfrey, P. A., Palmer, K. L., Bodi, K. L., Mongodin, E. F., et al. (2012) · mBio · doi:10.1128/mbio.00112-12 · Cited by 155
TREATMENT OF TUBERCULOSIS WITH STREPTOMYCIN
Hinshaw, C. H. (1946) · JAMA · doi:10.1001/jama.1946.02870480024007 · Cited by 150
Dolejská, M., Villa, L., Poirel, L., Nordmann, P., & Carattoli, A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks357 · Cited by 144
Yocum, R. R., Waxman, D. J., Rasmussen, J. R., & Strominger, J. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.6.2730 · Cited by 139
Richardson, J. F., & Reith, S. (1993) · Journal of Hospital Infection · doi:10.1016/0195-6701(93)90007-m · Cited by 137
Goossens, H., & Grabein, B. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.10.001 · Cited by 135
Waksman, S. A., & Woodruff, H. B. (1941) · Journal of Bacteriology · doi:10.1128/jb.42.2.231-249.1941 · Cited by 134
Bastos, M. L., Hussain, H., Weyer, K., García‐García, L., Leimane, V., Leung, C. C., Narita, M., Peña, J. M., Ponce‐de‐León, A., Seung, K. J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu619 · Cited by 131
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Evans, B. A., Hamouda, A., & Amyes, S. G. B. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811306020223 · Cited by 129
Penicillin Resistant Staphylococci
Bondi, A., & Dietz, C. C. (1945) · Experimental Biology and Medicine · doi:10.3181/00379727-60-15089 · Cited by 128
Lodge, J., Minchin, S., Piddock, L. J. V., & Busby, S. J. W. (1990) · Biochemical Journal · doi:10.1042/bj2720627 · Cited by 127
Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus
Cotroneo, N. S., Harris, R. J., Perlmutter, N. G., Beveridge, T. J., & Silverman, J. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-07 · Cited by 127
Poulikakos, P., Tansarli, G. S., & Falagas, M. E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2124-9 · Cited by 125
Origin and Evolution of European Community-Acquired Methicillin-Resistant Staphylococcus aureus
Stegger, M., Wirth, T., Andersen, P. S., Skov, R. L., Grassi, A., Martins-Simões, P., Tristan, A., Petersen, A., Aziz, M., Kiil, K., et al. (2014) · mBio · doi:10.1128/mbio.01044-14 · Cited by 124
First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
Melo‐Cristino, J., Resina, C., Manuel, V., Lito, L., & Ramirez, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61219-2 · Cited by 116
Current Treatment Options for Community‐Acquired Methicillin‐ResistantStaphylococcus aureusInfection
Moellering, R. C. (2008) · Clinical Infectious Diseases · doi:10.1086/529445 · Cited by 115
Harris, A. D., Perencevich, E. N., Johnson, J. K., Paterson, D. L., Morris, J. G., Strauss, S. M., & Johnson, J. A. (2007) · Clinical Infectious Diseases · doi:10.1086/522657 · Cited by 112
Tedesco, K. L., & Rybak, M. J. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.1.41.34802 · Cited by 110
Extended‐Spectrum β‐Lactamases
Turner, P. J. (2005) · Clinical Infectious Diseases · doi:10.1086/430789 · Cited by 102
Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States
Limbago, B. M., Kallen, A. J., Zhu, W., Eggers, P., McDougal, L. K., & Albrecht, V. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02187-13 · Cited by 101
Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid
Selikoff, I. J., & Robitzek, E. H. (1952) · Diseases of the Chest · doi:10.1378/chest.21.4.385 · Cited by 94
Patterns and Mechanisms of Antibiotic Resistance
Murray, B. E., & Moellering, R. C. (1978) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31746-1 · Cited by 93
Emergence of Antibiotic-Resistant Bacteria
Finland, M. (1955) · New England Journal of Medicine · doi:10.1056/nejm195512082532306 · Cited by 91
Vancomycin resistant Staphylococcus aureus in the United States
Woodford, N. (2002) · Weekly releases (1997–2007) · doi:10.2807/esw.06.28.01913-en · Cited by 91
Chemotherapy of Pulmonary Tuberculosis
Crofton, J. (1959) · BMJ · doi:10.1136/bmj.1.5138.1610 · Cited by 88
Yu, S., Girotto, S., Lee, C., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300326200 · Cited by 84
The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases
Metcalfe, C. L., Macdonald, I. K., Murphy, E. J., Brown, K. A., Raven, E. L., & Moody, P. C. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707412200 · Cited by 83
Acinetobacterinfections: a growing threat for critically ill patients
Falagas, M. E., Karveli, E. A., Siempos, I. Ι., & Vardakas, K. Z. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009478 · Cited by 82
Emergence of Antibiotic-Resistant Bacteria
Finland, M. (1955) · New England Journal of Medicine · doi:10.1056/nejm195511242532105 · Cited by 77
Glaziou, P., Floyd, K., Korenromp, E. L., Sismanidis, C., Bierrenbach, A. L., Williams, B. G., Atun, R. A., & Raviglione, M. C. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.087510 · Cited by 76
Tuberculosis control--is DOTS the health breakthrough of the 1990s?
Kochi, A. (1997) · PubMed · Cited by 74
Selective Antibiotic Action of Various Substances of Microbial Origin
Waksman, S. A., & Woodruff, H. B. (1942) · Journal of Bacteriology · doi:10.1128/jb.44.3.373-384.1942 · Cited by 72
Vikram, H. R., Havill, N. L., Koeth, L. M., & Boyce, J. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5384-5387.2005 · Cited by 71
Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change
Mira, P., Meza, J. C., Nandipati, A., & Barlow, M. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv146 · Cited by 57
Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control
Wyllie, D. H., Paul, J., & Crook, D. W. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr392 · Cited by 56
Ahmed, M. A. E.-G. E.-S., Amin, M. A., Tawakkol, W. M., Loucif, L., Bakour, S., & Rolain, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04412-14 · Cited by 55
Wyllie, D. H., Walker, A. S., Miller, R. R., Moore, C. E., Williamson, S. R., Schlackow, I., Finney, J. M., O’Connor, L., Peto, T., & Crook, D. W. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000160 · Cited by 54
Development of Drug Resistance to Rifampicin
Manten, A., & Wijngaarden, L. J. V. (2009) · Chemotherapy · doi:10.1159/000220615 · Cited by 53
Harris, P. N. A. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398387 · Cited by 53
Staphylococcus AureusColonization and the Risk of Infection in Critically Ill Patients
Keene, A. B., Vavagiakis, P., Lee, M., Finnerty, K., Nicolls, D. J., Cespedes, C. A., Quagliarello, B., Chiasson, M. A., Chong, D. H., & Lowy, F. D. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502591 · Cited by 41
Khatib, R., Sharma, M., Iyer, S. P., Fakih, M. G., Obeid, K. M., Venugopal, A. A., Fishbain, J. T., Johnson, L. B., Segireddy, M., Jose, J., et al. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.03.038 · Cited by 27
Totally drug‐resistant tuberculosis in India: Who let the djinn out?
Udwadia, Z. F. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02192.x · Cited by 22
Külah, C., Çelebi, G., Aktaş, E., et al. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.4.390 · Cited by 16
Cited by
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023) · Antibiotics · doi:10.3390/antibiotics12030557 · Cited by 293
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
Palmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00114 · Cited by 133
Yagnik, D., Ward, M., & Shah, A. J. (2021) · Scientific Reports · doi:10.1038/s41598-020-78407-x · Cited by 42
Metadata
- Authors
- Medina, E., & Pieper, D. H.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 398
- Pages
- 3-33
- ISSN
- 0070-217X (ISSN-L)
- 2196-9965
- OpenAlex
- W2480623096
- Cited by
- 356
- References
- 197
- FWCI
- 22.60
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.